
Viridian Therapeutics Inc
NASDAQ:VRDN

Wall Street
Price Targets
VRDN Price Targets Summary
Viridian Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VRDN
is 40.16 USD
with a low forecast of 19.19 USD and a high forecast of 64.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VRDN's stock price target?
Price Target
40.16
USD
According to Wall Street analysts, the average 1-year price target for
VRDN
is 40.16 USD
with a low forecast of 19.19 USD and a high forecast of 64.05 USD.
What is Viridian Therapeutics Inc's Revenue forecast?
Projected CAGR
836%
For the last 8 years the
compound annual growth rate for
Viridian Therapeutics Inc's revenue is
-26%.
The projected
CAGR
for the next 3 years is
836%.